Author Index Volumes 201–232 Author Index Vols

Author Index Volumes 201–232 Author Index Vols

Author Index Volumes 201–232 Author Index Vols. 26–50 see Vol. 50 Author Index Vols. 51–100 see Vol. 100 Author Index Vols. 101–150 see Vol. 150 Author Index Vols. 151–200 see Vol. 200 The volume numbers are printed in italics Achilefu S, Dorshow RB (2002) Dynamic and Continuous Monitoring of Renal and Hepatic Functions with Exogenous Markers. 222: 31–72 Albert M, see Dax K (2001) 215: 193–275 Angyal SJ (2001) The Lobry de Bruyn-Alberda van Ekenstein Transformation and Related Re- actions. 215: 1–14 Armentrout PB (2003) Threshold Collision-Induced Dissociations for the Determination of Accurate Gas-Phase Binding Energies and Reaction Barriers. 225: 227–256 Astruc D, Blais J-C, Cloutet E, Djakovitch L, Rigaut S, Ruiz J, Sartor V, Valrio C (2000) The First Organometallic Dendrimers: Design and Redox Functions. 210: 229–259 Aug J, see Lubineau A (1999) 206: 1–39 Baars MWPL, Meijer EW (2000) Host-Guest Chemistry of Dendritic Molecules. 210: 131–182 Balazs G, Johnson BP, Scheer M (2003) Complexes with a Metal-Phosphorus Triple Bond. 232: 1-23 Balczewski P, see Mikoloajczyk M (2003) 223: 161–214 Ballauff M (2001) Structure of Dendrimers in Dilute Solution. 212: 177–194 Baltzer L (1999) Functionalization and Properties of Designed Folded Polypeptides. 202: 39–76 Balzani V, Ceroni P, Maestri M, Saudan C, Vicinelli V (2003) Luminescent Dendrimers. Recent Advances. 228: 159–191 Balazs G, Johnson BP, Scheer M (2003) Complexes with a Metal-Phosphorus Triple Bond. 232: 1-23 Barr L, see Lasne M-C (2002) 222: 201–258 Bartlett RJ, see Sun J-Q (1999) 203: 121–145 Bertrand G, Bourissou D (2002) Diphosphorus-Containing Unsaturated Three-Menbered Rings: Comparison of Carbon, Nitrogen, and Phosphorus Chemistry. 220: 1–25 Betzemeier B, Knochel P (1999) Perfluorinated Solvents – a Novel Reaction Medium in Organ- ic Chemistry. 206: 61–78 Bibette J, see Schmitt V (2003) 227: 195–215 Blais J-C, see Astruc D (2000) 210: 229–259 Bogr F, see Pipek J (1999) 203: 43–61 Bohme DK, see Petrie S (2003) 225: 35–73 Bourissou D, see Bertrand G (2002) 220: 1–25 Bowers MT, see Wyttenbach T (2003) 225: 201–226 Brand SC, see Haley MM (1999) 201: 81–129 Bray KL (2001) High Pressure Probes of Electronic Structure and Luminescence Properties of Transition Metal and Lanthanide Systems. 213: 1–94 Bronstein LM (2003) Nanoparticles Made in Mesoporous Solids. 226: 55–89 Brnstrup M (2003) High Throughput Mass Spectrometry for Compound Characterization in Drug Discovery. 225: 275–294 Brcher E (2002) Kinetic Stabilities of Gadolinium(III) Chelates Used as MRI Contrast Agents. 221: 103–122 Brunel JM, Buono G (2002) New Chiral Organophosphorus atalysts in Asymmetric Synthesis. 220: 79–106 Subject Index Acid/azole complex 101 Bis(4-nitrophenyl)-N,N-diisopropyl- Acid salt, activation by 100 phosphoroamidite 106 Acrylate 30 1,2-Bis(dimethylphosphino)ethane 49 1-Adamantol 4 1,2-Bis(diphenylphosphino)ethane 29 Alkenes 25 Bis(phosphine)(acrylonitrile)platinum Alkenylpalladium 32 complex 28 Alkenylphosphinates, optically active 51 Bis(trimethylsilyl) peroxide 98 Alkenylphosphine oxide 47 1,2-Bisphosphonate 37 Alkenylphosphonates 39 Bis-phosphonio-1,2,4-diazaphospho- Alkynes 25 lide 181 –, addition to 45 –, reductive cleavage 184 –, aliphatic 32 –, X-ray diffraction study 187 –, hydrophosphinylation, rhodium- Bis-phosphonio-1,2-diphospholide 180 catalyzed 47 –, X-ray diffraction study 187 –, P(III)-H bond 31 Bis-phosphonio-benzophospholide 90 Alkynylphosphines 33 –, X-ray diffraction study 187 Allyl group 108 Boranophosphorothioate, 3',5'-cyclic 120 – – removal 112 B-P86/SVP 17 Aluminum 149, 158, 162–163, 167 2-Bromo-4,5-dicyanoimidazole 100 Ambidentate ligand 203 5-Bromopent-1-ene 52 Ambiphilicity 193 Bulkiness 151 Anion complexation 74 O-tert-Butyl-N,N,-diisopropylfluoro- Arabis mosaic virus (sArMV) 233 phosphoroamidite 128 Arbuzov-Michaelis reaction 26, 131, 134, 139 Cadmium 153, 159 3'-Azido-3'-dideoxythymidine-50-mono- (1S)-(+)-(10-Camphorsulphonyl) phosphate 122 oxaziridine 135 Azolide, activation by 96, 98 Carbon linkage, unsaturated 25, 26 Catalysis, homogeneous 25, 53 Back donation 202 Catalyst 154, 166, 168, 215, 217–248 Barium 159 Cavitand 58 Beaucage reagent 135 –, phosphorylated 63 3H-1,2-Benzodithiol-3-one 1,1-dioxide Charge transfer 201 (Beaucage reagent) 100 Chelate complex 199 O-Benzyl-O-2-cyanoethyl-N,N-diisopropyl- Chicory yellow mottle virus type 1 phosphoroamidite 111 (sCYMV1) 233 Biotin phosphoroamidite, photocleavable 2-Chloro-1,3,2-dithiaphospholane 138 122 Chromatography 166 Bis-O-(2-cyano-1,1-dimethylethyl)-N,N- Chromium 158 diethylphosphoroamidite 115 Cobalt 151, 153 Bis(9-fluorenylmethyl)-N,N-diisopropyl- Coordination shift 201–203 phosphoroamidite 118 Copper 148, 153, 160, 162 264 Subject Index Cryptand, phosphorus 57 Frontier orbital, influence on ligand 4-Cyano-2-butenyl protecting group 121 property 192 1-Cyano-2-phosphinoethyl)platinum 29 2-Cyanoethyl diisopropyl- Glycidol phosphate 107 chlorophosphoroamidite 122 Glycosylation 108 O-(2-Cyanoethyl) N,N-diisopropyl- Grafting 147, 162, 165 phosphorofluoramidite 128 Grignard reactions 26 Cyclohexensulfide 10 Cyclopentene 42 Hairpin ribozymes 214, 233 Cytidine-5'-monophospho-N-acetylneura- Haloarcula marismortui 244 minic acid 102–103 Hammerhead ribozymes 214, 219 Hapticity 152 Dearylation, reductive 183 HDV ribozymes 214, 228, 243 Dewar-Chatt-Duncanson model 176 Hemicryptophane 84 Dialkyl(cyanomethyl) ammonium Hepatitis delta virus (HDV) ribo- tetrafluoroborate 101 zymes 214, 228, 243 Diallyl diisopropylphosphoroamidite 111 Hetero-bimetallic complex 204 Dibenzyl diisopropylphosphoro- Heterocumulenes 12 amidite 107, 109 HF 153–154 4,5-Dicyanoimidazole 99 Horner-Emmons olefination 45 1,3-Dicyclohexylcarbodiimide (DCC) 109 H-P addition 25, 53 Dienes 25, 44 Hydroformylation catalyst 208, 209 1,3-Dienesa, hydrophosphination 45 Hydrogen peroxide 156 2-N,N-Diisopropylamino-1,3,2-oxathia- Hydrogen phosphinates 50 phospholane 137 Hydrogen phosphonate 36 N,N-Diisopropyl-bis[(trimethylsilyl)ethyl]- Hydrophosphination, alkynes 37, 40 phosphoroamidite 117 –, asymmetric 30 N,N-Diisopropyl-di-(4-nitrophenyl) phos- Hydrophosphinylation 45 phoroamidite 124 Hyperconjugation 192 N,N-Diisopropyl-4-nitrophenylmethyl- Hypophosphite, addition 52 phosphonoamidite 132 9,9-Dimethyl-4,5-bis(diphenylphosphino)x- Iminophosphenium cations 7 anthene 52 Iminophosphines 7 Dimethyl 1-octen-2-ylphosphonate 36 Indium 155 Dimethyl phosphonate 36, 38 Indium–tin 162 2,4-Dinitrophenol, activation by 103 Intercalation 153 Dinucleoside arylphosphite 125 Iridium 168 Dinucleoside phosphorofluoridite 128 Iron 162 Dioxaphospholane 2-oxide 41 Isophosphindole 178 Diphenylacetylene 32, 50 Isoprene 44 Diphenylphosphine oxide 46 Diphenylphosphinic acid 48 Lanthanide-catalyzed addition 33 4-Diphenylphosphino-1-butoxyl 35 Lanthanide phosphide 35 1,2-Diphosphaindenide 181 Lanthanocene phosphine-phosphide 34 Dithymidine phosphorothioate 99 Lewis acids 11 Lithium-bis(trimethylsilyl)phosphanide 6 2-Electron-3-centre bond 207 Macrocycle 57 Ethyl acrylate 30 Magnesium 159 1-Ethynylcyclohexene 37 Magnetic property 148 Manganese 152 Flame retardant 26 (–)-Menthyl phenylphosphinate 50 Fluoride/fluorine 154, 156 Metal ion binding site A9/G10.1 227 Fluorophosphoroamidite 127 Metallacycle 202, 205 Fmoc/tert-butyl strategy 117 Metalloenzymes 218 Subject Index 265 Metallo-phospha-cyclobutadiene Phosphahemispherand 57 derivatives 13 Phosphatocavitand 64 Metal-phosphorus triple bond, Phosphido hydrido complex 29 complexes 1 Phosphido ligand complexes, Metathesis 4, 9, 13–14 asymmetrically bridged 13 2-(Methacryloyloxy)ethylphosphoryl- – – –, terminal 3 choline 138 Phosphido ligands 1, 2 3-Methyl-2-buten-1-ylphosphonate 44 Phosphinates, P-chiral 50 1-Methylcyclohexanol 4 Phosphine oxides, secondary 36, 45 O-Methyl-O-4-nitrophenyl-N,N-diisopropyl- Phosphinic acid 48 phosphoroamidite 123 Phosphinidene complexes 1 Methylphosphonate 43 – –, linear coordinated 19 Methyl(phosphoryl)palladium complexes Phosphinyl-moiety, regioselective 43 quaternisation 186 Mg2+ 219–243 Phosphinyl(phosphinato)palladium Micropore 155 complex 49 Microporous compound 149, 152, 155 Phosphitylating reagent 95 Mitsunobu reaction 134 Phosphocavitand 59 Molecular capsule 79 Phosphodiester bond, cleavage 215 Molecular sieves MS13X 97 Phospholide, phosphonio-substituted, Molybdenum phosphides 8 NMR/UV-VIS 188 Monolayer 164 Phospholipid 107 Mononucleoside fluorophosphoro- Phosphonato cavitand 66 amidite 128 3-Phosphonio-benzo-1,2-diphospholide Monophosphadiazonium ligand 10 181 Myo-inositol 2,4,5-triphosphate 107 Phosphonio-phospholide, electrophilic alkylation 194 Ni[P(OEt)3]4 31 – –, monocyclic 179 4-Nitrophenylethyl protecting group 114 – –, nomenclature 178 5-(4-Nitrophenyl)-1H-tetrazole 97 – –, selective reduction 184 NMR spectroscopy, 31P- 4, 6 Phosphonoamidite 131 Norbornene 42 –, diastereo pure 102 Nucleobase 219, 224, 229–234, 243–248 Phosphopeptide, caged 116 Nucleoside a-P-borano 137 Phosphoroamidite 95 –, aryloxy ligand 123 1-Octyne 36, 46 –, tert-butyl protecting groups 113 Olefins, activated, hydrophosphination 30 –, O-tert-butyl-O-2-cyanoethyl-N,N-diiso- Organophosphorus compounds, propylphosphoroamidite, homogeneous catalysis 25 asymmetrically-protected 113 – –, P-chiral 50 –, 3',5'-cyclic 120 Oxidation 194 –, monofunctional 107 Oxidative alcoholysis 196 –, polyfunctional 118 Phosphorodithioic acid derivative 134 P-Cl bond, spontaneous heterolysis 179 Phosphorothiolate RNA 217 P-H bonds 25 Phosphorus cavitand 61 Pd-diphenylphosphinic acid 50 – cryptand 57 Peptidyl transferase 244 – ligands

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    18 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us